As the global economy mends, the 2021 growth of Home Use CGM System will have significant change from previous year. According to our (LP Information) latest study, the global Home Use CGM System market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Home Use CGM System market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Home Use CGM System market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Home Use CGM System market, reaching US$ million by the year 2028. As for the Europe Home Use CGM System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Home Use CGM System players cover Abbott Laboratories, Dexcom, Inc., Medtronic plc, and Insulet Corp., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Home Use CGM System market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Retrospective CGM
Real-Time Monitoring
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Elderly
Adults
Pediatric
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott Laboratories
Dexcom, Inc.
Medtronic plc
Insulet Corp.
F. Hoffmann-La Roche AG
Ascensia Diabetes Care Holdings AG
AgaMatrix, Inc.
Integrity Applications, Inc.
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech